surmount trials tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide - A New Dawn

22 One study had moderate concerns with a low participation rate, no confounder adjustment, and moderate risks in selection of participants and reported results, as well as deviations from intended interventions (ESM eFig

A better understanding of the intersecting pathophysiology of HFpEF and AF reveals therapeutic targets that can address both conditions

Ozempic has been used off-label to treat conditions like PCOS

Improvements in prefilled pen designs, dosing accuracy, and storage stability are making home administration more accessible for a broader patient population

In fact, the differences between them are significant enough that choosing one over the other could meaningfully affect results, side effects and suitability